$5.81
-0.16-2.68%
At close: -
$5.76
-0.05-0.86%
After Hours: 7:59 PM EDT
Comments
Loading...
Recursion Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:RXRX | Benzinga
Recursion Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.480
Quarterly Revenue Estimate
$12.00M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$58.49M
Analyze the earnings history of Recursion Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals | -$0.39 | -$0.48 | — | — | $13.49M | $12.00M | — | — | 05/08/2025 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.42 | -$0.42 | -$0.53 | -26.19% | $10.89M | $19.04M | $4.55M | -76.12% | 02/28/2025 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.43 | -$0.35 | -$0.34 | 2.86% | $10.53M | $29.84M | $26.08M | -12.59% | 11/06/2024 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.38 | -$0.40 | -$0.40 | 0.00% | $11.02M | $13.75M | $14.42M | 4.85% | 08/08/2024 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.34 | -$0.42 | -$0.39 | 7.14% | $12.13M | $12.65M | $13.49M | 6.65% | 05/09/2024 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.31 | -$0.45 | -$0.42 | 6.67% | $13.68M | $20.53M | $10.89M | -46.95% | 02/27/2024 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.35 | -$0.38 | -$0.43 | -13.16% | $13.16M | $12.87M | $10.53M | -18.16% | 11/09/2023 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.38 | -$0.37 | -$0.38 | -2.70% | $7.67M | $11.91M | $11.02M | -7.50% | 08/08/2023 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.33 | -$0.35 | -$0.34 | 2.86% | $5.33M | $14.44M | $12.13M | -15.97% | 05/08/2023 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.38 | -$0.29 | -$0.31 | -6.90% | $2.53M | $24.00M | $13.68M | -43.02% | 02/27/2023 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.28 | -$0.38 | -$0.35 | 7.89% | $2.53M | $6.97M | $13.16M | 88.81% | 11/08/2022 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.31 | -$0.40 | -$0.38 | 5.00% | $2.55M | $5.40M | $7.67M | 42.11% | 08/09/2022 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$1.33 | $0.10 | -$0.33 | -430.00% | $2.56M | $83.95M | $5.33M | -93.65% | 05/10/2022 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$1.17 | -$0.31 | -$0.38 | -22.58% | $2.70M | $6.07M | $2.53M | -58.27% | 03/23/2022 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$1.09 | -$0.28 | -$0.28 | 0.00% | $1.02M | $2.62M | $2.53M | -3.28% | 11/10/2021 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.88 | -$0.23 | -$0.31 | -34.78% | — | $2.72M | $2.55M | -6.29% | 08/13/2021 | Get Alert |
| RXRX | Recursion Pharmaceuticals | -$0.85 | — | -$1.33 | — | $60.00K | — | $2.56M | — | 05/12/2021 | Get Alert |
Recursion Pharmaceuticals (RXRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-28 | $-0.53 | $-0.42 | -26.2 % |
| Q3 | 2024-11-06 | $-0.34 | $-0.35 | 2.86 % |
| Q2 | 2024-08-08 | $-0.40 | $-0.40 | 0.00 % |
| Q1 | 2024-05-09 | $-0.39 | $-0.42 | 7.14 % |
Recursion Pharmaceuticals (RXRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-28 | $4.55M | $19.04M | -76.1 % |
| Q3 | 2024-11-06 | $26.08M | $29.84M | -12.6 % |
| Q2 | 2024-08-08 | $14.42M | $13.75M | 4.85 % |
| Q1 | 2024-05-09 | $13.49M | $12.65M | 6.65 % |
FAQ
When is Recursion Pharmaceuticals (NASDAQ:RXRX) reporting earnings?
Recursion Pharmaceuticals (RXRX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 28, 2025 for Q4.
What were the latest earnings per share (EPS) for Recursion Pharmaceuticals (NASDAQ:RXRX)?
The Actual EPS was $-0.53, which missed the estimate of $-0.42.
What were Recursion Pharmaceuticals’s (NASDAQ:RXRX) revenues?
The Actual Revenue was $4.5M, which missed the estimate of $19M.
Browse earnings estimates, EPS, and revenue on all stocks.